MTS Health Partners served as exclusive financial advisor to Biora Therapeutics through Chapter 11, securing DIP financing and the 363 sale to the DIP lenders. Biora will continue to focus on developing its smart pill therapeutics platform, designed to replace injections with oral delivery.?
关于我们
MTS Health Partners is a leading healthcare-dedicated investment bank that provides strategic and financial advice to the healthcare industry, from global public corporations to venture-backed businesses. Since 1999, MTS has offered our clients unmatched strategic and M&A advisory services, equity and structured financing expertise. Our team of over 60 bankers is one of the industry’s largest healthcare advisory groups, fostering trusted client partnerships with true alignment to help clients achieve their goals. We provide our clients with creative thinking, candid advice, and commitment to results, advising them in pursuing the right strategic path rather than simply focusing on transactions. Through close client partnerships based on trust and shared commitment, we are at your side and on your side, every step of the way. For more information, please visit https://www.mtspartners.com/
- 网站
-
https://www.mtspartners.com
MTS Health Partners的外部链接
- 所属行业
- 投资银行业务
- 规模
- 51-200 人
- 总部
- New York，NY
- 类型
- 私人持股
- 创立
- 1999
- 领域
- Strategic Advice & Financing
地点
MTS Health Partners员工
动态
-
MTS Health Partners is pleased to present February’s Month in Review which covers the latest happenings in the Life Sciences sector including M&A and financing activity, key industry news, upcoming PDUFAs, data catalysts and industry medical conferences.??If you’d like to be included in the monthly newsletter please email [email protected].?
-
MTS Health Partners is pleased to serve as financial advisor to BLUE WOLF CAPITAL PARTNERS LLC in regards to the creation of its new CDMO platform which combines the acquisitions of Recipharm and SYNERLAB GROUP
-
-
MTS Health Partners is pleased to present January’s Month in Review which covers the latest happenings in the Life Sciences sector including M&A and financing activity, key industry news, upcoming PDUFAs, data catalysts and industry medical conferences.??If you’d like to be included in the monthly newsletter please email [email protected].
-
MTS Health Partners is pleased to announce that our client, Quartet Health, has been acquired by NeuroFlow, a behavioral health technology and analytics company. This follows the successful carve-out and sale of Quartet’s telepsychiatry subsidiary, innovaTel (now Iris Telehealth), to Iris Telehealth. Terms of the transactions were not disclosed.? ? MTS served as the exclusive financial advisor to Quartet Health for both transactions. https://lnkd.in/e-cAExUm #healthcare #investmentbanking #behavioralhealth
-
-
MTS Health Partners is delighted to recognize the hard work and dedication of our talented team members with well-deserved promotions. They are helping to shape the future of MTS, and we are pleased to celebrate their achievements.?Please join us in congratulating our talented colleagues!?Frank Walker Jessica Sanyour Christian Lewis Kristin Dilmore John Lewis Stuart Sweeney Dhruv Jaggia Steven Szalay Jeremy Benton Ryoko Suzuki Ruei-Shyuan Lee #promotions
-
-
Ryan Stewart is speaking on a webinar hosted by Chasm Partners, Wednesday January 8th at 12pm ET.?Don’t miss his outlook on 2025 Healthcare Investing.?To register please visit https://lnkd.in/eqpjvX_C
-
-
MTS Health Partners served as exclusive financial advisor to Immedica Pharma AB in its acquisition of Marinus Pharma.?To read more about the transaction please visit https://lnkd.in/e93kn9XF
-
-
MTS Health Partners is pleased to present November's Month in Review which covers the latest happenings in the Life Sciences sector including M&A and financing activity, key industry news, upcoming PDUFAs, data catalysts and industry medical conferences.??If you’d like to be included in the monthly newsletter please email [email protected]